Organogenesis Holdings Inc.ORGO
Market cap
$612.7M
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | - | - | - | - | - | - | - | 14 |
| Stock-based compensation | - | - | 1 | 1 | 2 | 4 | 7 | 9 | 11 |
| Cash from operations | -562,233 | -586,604 | -61 | -34 | 7 | 62 | 25 | 31 | 14 |
| Capital expenditures | - | - | -2 | -6 | -21 | -31 | -34 | -24 | -10 |
| Cash from investing | -310,000,000 | - | -2 | -6 | -25 | -31 | -34 | -24 | -10 |
| Repurchases of common stock | - | - | - | - | - | - | - | - | 25 |
| Cash from financing | 311 | -327,578 | 82 | 79 | 42 | -1 | -2 | -6 | 28 |
| Free cash flow | - | - | |||||||
| FCF margin (%) | - | - |